ArticleACS infectious diseases2025
Examination of Acetylated Monosaccharides as Metabolic Probes in Bacteria.
Article in ACS infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of Fluorogenic Probes to Detect Glycan-Degrading Enzymes in Bacteria.ACS infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Bacterial glycans are validated antibiotic targets due to their crucial roles in supporting bacterial fitness and survival. The array of exclusively bacterial monosaccharides and their variable expression across bacterial species and serotypes present challenges in studying these structurally diverse molecules. Probes based on bacterial sugars have emerged as useful tools in metabolic labeling studies. Prior to the metabolic processing of probes by bacteria, most metabolic probes must be transported across the bacterial cell envelope. Probe acetylation has been used as one strategy to ease passive diffusion across the lipophilic cell membrane and relies on deacetylation by esterases within cells before subsequent metabolic processing into glycans is possible. However, inefficient probe deacetylation has the potential to yield artifactual labeling rather than physiological glycan labeling. Here, we systematically explored probe acetylation as a design criterion for metabolic labeling experiments in four bacterial species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.